Peptides: Benefits, Types, How They Work & Responsible Use

Peptides Scored So Far

Being scored next, with no number published yet: collagen peptides, thymosin alpha-1, GHK-Cu, TB-500, KPV, epitalon, Semax, CJC-1295 with ipamorelin, MOTS-c, and the prescription compounds semaglutide and teriparatide. Each gets its own page and its own number once the evidence review is finished. Until then this page names them without rating them, and the ranking further down the article is my editorial read on use, benefit and evidence, not a score.

Dr. Josh Axe · Free quiz

Real Age Quiz

Loading question one…

Advertisement

Advertisement

What are peptides?

In more than two decades of clinical practice, I've watched the conversation around peptides move from the fringes of sports medicine into mainstream functional medicine, and for good reason. Peptides are not some foreign chemistry we impose on the body. They are the body's own language. Amino acids are the building blocks of every protein you have. String a handful of them together and you get a peptide, a molecule small enough to be exquisitely specific yet powerful enough to set off a cascade that reaches all the way to gene expression.

The difference between an amino acid, a peptide, and a protein comes down to size and job. An amino acid is a single letter. A peptide is a short word or sentence. A protein is an entire book. That compactness is exactly what makes peptides useful as signals, since they're fast-acting, often absorbed more readily than whole proteins, and highly targeted in what they tell the body to do.

Small enough to be specific. Big enough to carry a message.

Amino acids are the raw letters, peptides are short words and sentences, and proteins are entire books. Peptides are compact and fast-acting, which is what lets them work as precise biological signals.

Peptides are not steroids

This is the single most common misunderstanding I correct in clinic. Anabolic steroids flood the body with synthetic hormones and can shut down your own production. Most signaling peptides work the opposite way. They reinforce and restore the rhythms already written into you, nudging a gland or a tissue to do its job rather than taking that job over. That's a meaningful distinction. It does not, however, mean peptides are risk-free, and it does not mean every peptide sold online is safe or legal. The specific compound, its sourcing, and your clinician's oversight are what matter.

Peptides aren't silver bullets. They're messengers that tap into the body's own communication network to trigger repair, calm inflammation, and rebuild tissue. The body already knows how to heal. Peptides simply hand it more of the right instructions.

Peptides are made in your own body

Here's the part that grounds all of this. Peptides aren't a laboratory invention. They are naturally occurring molecules your organs and glands produce around the clock. Right now your body is making thousands of different peptides every second, closing a wound, timing your sleep, steadying your blood sugar, calming inflammation. Each gland is, in effect, its own small peptide factory, and many of the therapeutic peptides people talk about today are simply concentrated versions of signals you already make.

The thymus is the clearest example. This small gland sitting behind the breastbone is the training ground of the immune system, and it is rich in a family of peptides called thymosins, among them thymosin alpha-1, which helps balance and sharpen immune defense,8 and thymosin beta-4, the naturally occurring repair peptide that is the parent of TB-500.5 When you read about those peptides as therapies, you're reading about compounds the body already manufactures in that one gland. The same pattern holds across the body.

Glandulars were the original peptide supplement

Long before the word peptide existed, traditional healers were already using this principle through glandular therapy, the original peptide supplement. The guiding idea was "like supports like." Eat thymus to bolster immunity, liver to strengthen the liver, because those organ tissues are dense in the very peptides the body recognizes for repair and regulation. Bone broth, organ meats, colostrum, and similar whole foods have nourished this system for as long as people have eaten nose-to-tail. Modern peptide therapy is that same ancient idea, refined by isolating the specific messenger and delivering it cleanly.

The simplest way to understand it is the way we already think about vitamins. Your body and your food contain vitamin C, but a supplement delivers a concentrated, higher dose than a single orange ever could. Peptide therapy works on exactly the same logic. It concentrates and amplifies the signals your organs already make and your food already supplies, delivering a focused, higher dose of a messenger the body already knows how to use. That is why peptides tend to feel less like a foreign drug and more like turning up a signal the body has been sending all along.

Peptide benefits, ranked by evidence

Here is a map of what peptides are studied to do, and how strong the evidence is in each area. I've ranked these by the weight of the human research, because there's a real difference between a benefit that's proven and one that's promising. For peptide drugs that have cleared FDA review, the data is strong. For many wellness peptides, the mechanism is well defined and the preclinical work is compelling, but the large human trials are still catching up, in part because off-patent and compounded compounds attract less of the expensive late-stage trial funding that brings a drug to approval.

How peptides work in your body

Almost every therapeutic peptide works the same fundamental way. It binds to a receptor, a lock built for that specific key, and that binding sets off a cascade inside the cell. Depending on the peptide and the tissue, that cascade might drive protein synthesis, switch on repair programs, modulate immune activity, prompt a gland to release a hormone, or even influence which genes are expressed. The peptide delivers the message and then steps back. It's a signal, not a sledgehammer.

• Repair tissue

• Balance immunity

• Release a hormone

• Shift gene expression

A signal, not a sledgehammer — it tells the cell what to do, then steps back.

Most therapeutic peptides work by binding a receptor and triggering a cascade, reinforcing the body's own instructions rather than overriding them.

That mechanism is why peptides tend to have a different risk profile than drugs that override biology. They generally amplify pathways the body already runs, which is also why they work best when the basics (nutrition, sleep, movement, stress) are in place. The most advanced peptide can't outrun a diet that's starving the cell of what it needs to rebuild.

• Bind a receptor and trigger a targeted signaling cascade
• Stimulate angiogenesis, new blood vessels that feed rebuilding tissue3
• Recruit repair cells to sites of injury and inflammation5
• Modulate immune activity, up or down, toward balance8
• Prompt glands to release the body's own hormones12

Types of peptides: the six healing families

To make a sprawling field navigable, it helps to group peptides by the system they speak to. Here are the six functional families I use to organize peptide therapy, with an evidence grade for each, because they are not equal. Most real protocols draw from two or three families at once, because the body heals as a whole, not in parts.

A quick word on bioregulators, ultra-short peptides, often just two to four amino acids, pioneered by Russian researcher Vladimir Khavinson and proposed to deliver organ-specific repair signals. The longevity research is provocative, including reports of telomerase activation,11 but most of it is animal-based or from smaller studies that haven't been widely replicated. File bioregulators under promising and unproven.

The top 25 peptides, ranked

Patients and physicians ask me the same question constantly: of all the peptides out there, which ones truly matter? Below is my composite ranking of 25, weighing three things together: how widely a peptide is used, how broad and meaningful its benefits are, and how strong the evidence behind it is. The peptides at the very top are FDA-approved medicines with the deepest human data. As you move down, the use cases get more specialized and the research gets earlier, from proven, to promising, to preclinical.1 The evidence column uses the same grading as the rest of this guide, so you can see exactly where each one stands.

How to read this: a high rank is not a recommendation to use that peptide, and a lower rank does not mean a peptide is weak. LL-37 is powerful precisely because it works. Rank reflects the combination of how broadly a peptide is used, how meaningful its benefits are, and how mature the human evidence is today. The approved medicines near the top simply have the deepest research and the widest real-world track record. Where you start should always be decided with a clinician who knows your story.

A few of the entries beyond the original guide each carry their own research worth noting. Specific collagen peptides improved skin elasticity in a placebo-controlled trial,21 oral glutathione raised the body's glutathione stores in a randomized controlled trial and is also delivered intravenously in clinical practice,22 and PT-141 (bremelanotide) earned FDA approval for low sexual desire on the strength of two randomized phase 3 trials.23

Peptides begin on your plate: peptide-rich foods

Before any injection, the body's first peptide pharmacy is food, and this is where the evidence is friendliest and the risk is lowest. Whole-food sources deliver peptides along with the cofactors your body needs to put them to use. This is where I tell almost everyone to start.

• Bone broth, glycine, glutamine, and collagen, the raw materials for gut and connective-tissue repair
• Liver and organ meats, among nature's richest peptide and cofactor sources
• Collagen peptides, among the best-studied dietary peptides for skin, joints, and the gut lining
• Colostrum, immune and growth peptides with reasonable research for gut and immune support
• Wild-caught fish (salmon, sardines, cod), marine peptides plus the omega-3s and minerals peptides depend on
• Pasture-raised eggs and poultry, choline and complete, highly digestible protein for repair
• Grass-fed beef and lamb, complete protein and the amino acids that build the body's own peptides
• Spirulina, concentrated peptide content with antioxidant cofactors

Pair these foundational foods with warm, cooked, easy-to-digest meals like soups, steamed vegetables, and baked fruit, and you nourish the body at both the everyday and the therapeutic level. Food is the foundation that every peptide protocol is built on.

Forms and how peptides are delivered

Because peptides behave like miniature proteins, stomach acid and digestive enzymes can destroy them. How you take a peptide often decides whether it works at all, which is why route is always matched to where the peptide needs to act.

Are peptides FDA-approved? Where the regulation stands

The regulatory picture is shifting in real time. In September 2023, the FDA placed BPC-157 and a number of other peptides in a restricted category for compounding, citing questions about safety, purity, and the lack of human data, which effectively stopped licensed compounding pharmacies from preparing them. In 2026 that began to change. The FDA removed BPC-157 from that restricted category in April 2026, and the agency's Pharmacy Compounding Advisory Committee reviewed BPC-157, KPV, TB-500, and MOTS-c on July 23, 2026, and narrowly voted to recommend adding them to the list of substances allowed for pharmacy compounding.2829 The vote is advisory, and the list changes only through FDA rulemaking. Until the FDA acts, these compounds remain high-risk and tightly contested. The World Anti-Doping Agency, for instance, has banned BPC-157 since 2022.

One myth worth clearing up. You'll sometimes read that peptides are "suppressed because they can't be patented." That isn't accurate. Peptides are routinely patented, and semaglutide is one of the most valuable patented drugs in the world. The real reason many wellness peptides aren't approved is simpler. They haven't completed the large, expensive human trials that approval requires, and there's been less commercial incentive to fund that work for compounds that are off-patent or sold as research chemicals. The mechanism may be sound, but proof is what protects patients, and for many of these peptides the proof is still being gathered.

A balanced look at GLP-1s (semaglutide and tirzepatide)

GLP-1 receptor agonists are peptide-class drugs and the most widely used peptides on earth right now. They deserve a clear-eyed view from both sides. They work, often dramatically, for blood sugar and weight, with strong randomized evidence behind them.16 Tirzepatide, the dual GIP/GLP-1 drug, produces even larger average weight loss, around 21% in its main obesity trial.19 That upside is real, and for the right patient I don't want to minimize it.

The trade-offs are just as real, and the most important one is muscle. The number matters here, so let me be specific. In the STEP 1 trial's body-composition data, about 45% of the weight people lost on semaglutide was lean mass rather than fat, roughly 6.9 kg of the 15.3 kg lost.1618 Lean tissue is mostly the muscle that drives metabolism, strength, and healthy aging, so that is a serious concern. Rapid, profound appetite suppression can also push people toward too little protein and too few micronutrients, edging toward malnutrition when intake isn't watched closely. Nausea and digestive issues are common. And the benefit depends on continued use, and when semaglutide was stopped in a controlled study, participants regained much of the weight they had lost.17 The long-term picture, especially what years of use or cycling on and off does to muscle and metabolism, is still thin.

To make that concrete, picture someone who loses 20 pounds on one of these drugs. At the STEP 1 ratio, about 9 of those pounds would be lean mass, much of it muscle, not fat. After about age 30, the body naturally loses only a few percent of its muscle each decade.20 So shedding roughly 9 pounds of muscle in well under a year can equal one to two decades of normal age-related muscle loss, depending on body size, in effect aging your muscles by something like 20 years, compressed into a few months. That is exactly why dose, protein, and resistance training matter so much.

This is where the functional-medicine lens matters most. As with every peptide, the dose decides whether something is the medicine or the poison. Many thoughtful clinicians now favor microdosing GLP-1s, smaller, carefully titrated amounts under supervision, to capture the metabolic benefit while limiting muscle loss and side effects, rather than pushing to the highest tolerated dose. It is a more measured way to use a powerful tool.

And remember that your body makes its own GLP-1 every day, and you can support that production naturally with no side effects. Eating adequate protein and plenty of fiber at meals stimulates your own GLP-1 release and steadies blood sugar,24 while regular resistance training protects the very muscle a drug can quietly cost you. GLP-1 drugs address a symptom; the root is usually metabolic dysfunction driven by diet, stress, sleep, and inflammation. Used inside a real metabolic-health plan, not as a standalone shortcut, and at the lowest effective dose, they can be a powerful ally.

Peptides vs. hormone replacement therapy

Both can play a role, but they work differently, and understanding the difference helps you and your clinician choose well.

HRT is an important, appropriate tool for many people, especially when hormone levels are truly low. The point isn't that one approach is good and the other bad. It's that both belong inside a comprehensive plan (nutrition, lifestyle, targeted support) at the lowest effective dose, under medical guidance.

Safety, sourcing & responsible use

Peptides are powerful precisely because they speak the body's language, and that power deserves respect. Used appropriately and under supervision, many peptides are well tolerated. The risk rises sharply with poor sourcing and unsupervised use.

How to get started with peptides

If you're curious about peptides, here's the same path I'd give a patient or a family member: build the foundation first, then layer in precision tools under guidance.

1. Start with food. Bring in bone broth, collagen, organ meats, wild fish, and eggs. This is the safest, most foundational peptide source and needs no prescription.
2. Optimize the basics. Sleep, resistance training, blood-sugar-steady meals, and stress repair set the stage for any peptide to work better.
3. Find a qualified practitioner. Look for a functional or integrative physician trained in peptide therapy who will look at your whole picture, not just hand you a vial.
4. Begin with well-tolerated repair peptides, under guidance, rather than the most aggressive compounds, and respect sourcing and sequencing.
5. Monitor and adjust. Track how you respond, retest where appropriate, and let your clinician fine-tune the plan over time.

The bottom line

Peptides: frequently asked questions

References

1. Wang L, Wang N, Zhang W, et al. Therapeutic peptides: current applications and future directions. Signal Transduct Target Ther. 2022;7(1):48. PMID:35165272
2. Muttenthaler M, King GF, Adams DJ, Alewood PF. Trends in peptide drug discovery. Nat Rev Drug Discov. 2021;20(4):309-325. PMID:33536635
3. Seiwerth S, Rucman R, Turkovic B, et al. BPC 157 and standard angiogenic growth factors: gastrointestinal tract healing, lessons from tendon, ligament, muscle and bone healing. Curr Pharm Des. 2018;24(18):1972-1989. PMID:29998800
4. Gwyer D, Wragg NM, Wilson SL. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell Tissue Res. 2019;377(2):153-159. PMID:30915550
5. Goldstein AL, Hannappel E, Kleinman HK. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med. 2005;11(9):421-429. PMID:16099219
6. Dalmasso G, Charrier-Hisamuddin L, Nguyen HTT, et al. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008;134(1):166-178. PMID:18061177
7. Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987. PMID:29986520
8. King R, Tuthill C. Immune modulation with thymosin alpha 1 treatment. Vitam Horm. 2016;102:151-178. PMID:27450734
9. Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443-454. PMID:25738459
10. Szeto HH. First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. Br J Pharmacol. 2014;171(8):2029-2050. PMID:24117165
11. Khavinson VKh, Bondarev IE, Butyugov AA. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bull Exp Biol Med. 2003;135(6):590-592. PMID:12937682
12. Teichman SL, Neale A, Lawrence B, et al. Prolonged stimulation of growth hormone and IGF-I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006;91(3):799-805. PMID:16352683
13. Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-561. PMID:9849822
14. Dhillo WS, Chaudhri OB, Patterson M, et al. Kisspeptin-54 stimulates the hypothalamic-pituitary-gonadal axis in human males. J Clin Endocrinol Metab. 2005;90(12):6609-6615. PMID:16174713
15. Falutz J, Allas S, Blot K, et al. Metabolic effects of a growth hormone-releasing factor in patients with HIV. N Engl J Med. 2007;357(23):2359-2370. PMID:18057338
16. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002. PMID:33567185
17. Wilding JPH, Batterham RL, Davies M, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab. 2022;24(8):1553-1564. PMID:35441470
18. Neeland IJ, Linge J, Birkenfeld AL. Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies. Diabetes Obes Metab. 2024;26(Suppl 4):16-27. PMID:38937282
19. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205-216. PMID:35658024
20. Volpi E, Nazemi R, Fujita S. Muscle tissue changes with aging. Curr Opin Clin Nutr Metab Care. 2004;7(4):405-410. PMID:15192443
21. Proksch E, Segger D, Degwert J, et al. Oral supplementation of specific collagen peptides has beneficial effects on human skin physiology: a double-blind, placebo-controlled study. Skin Pharmacol Physiol. 2014;27(1):47-55. PMID:23949208
22. Richie JP Jr, Nichenametla S, Neidig W, et al. Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. Eur J Nutr. 2015;54(2):251-263. PMID:24791752
23. Kingsberg SA, Clayton AH, Portman D, et al. Bremelanotide for the treatment of hypoactive sexual desire disorder: two randomized phase 3 trials. Obstet Gynecol. 2019;134(5):899-908. PMID:31599840
24. Bodnaruc AM, Prud'homme D, Blanchet R, Giroux I. Nutritional modulation of endogenous glucagon-like peptide-1 secretion: a review. Nutr Metab (Lond). 2016;13:92. PMID:27990172
25. Al Musaimi O. Exploring FDA-approved frontiers: insights into natural and engineered peptide analogues in the GLP-1, GIP, GHRH, CCK, ACTH, and α-MSH realms. Biomolecules. 2024;14(3):264. PMID:38540684
26. Ionescu M, Frohman LA. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. J Clin Endocrinol Metab. 2006;91(12):4792-4797. PMID:17018654
27. Anisimov VN, Khavinson VKh, Popovich IG, et al. Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice. Biogerontology. 2003;4(4):193-202. PMID:14501183
28. U.S. Food and Drug Administration. FDA Briefing Document: Pharmacy Compounding Advisory Committee (PCAC) Meeting, July 23-24, 2026, Introduction.
29. Steinzor P. FDA panel backs 6 peptides for compounding. AJMC. July 31, 2026.

Dr. Josh Axe, DC, DNM, CNS

Doctor of Natural Medicine · Founder, DrAxe.com

Dr. Axe is a certified doctor of natural medicine, clinical nutritionist, and multiple New York Times bestselling author. He has spent 20+ years in clinical practice helping people heal at the root cause and founded one of the most-visited natural-health platforms in the world.

Read the full bio →

Medically reviewed by the DrAxe.com Medical Advisory Board on Jun 6, 2026.

Talk with a qualified, licensed physician before beginning any peptide therapy, especially if you have a medical condition, take other medications, are pregnant or breastfeeding, or have a history of cancer.